ClinicalTrials.Veeva

Menu

Pathology of Helicases and Premature Aging: Study by Derivation of hiPS (HeliPS)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Terminated

Conditions

Age Problem

Treatments

Other: taking of cutaneous cells

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Topic of this work is the involvement of replicative helicases in human premature ageing syndrome. Replicative helicases are ubiquitous and essential during numerous reactions of the DNA metabolism.

The family of replicative helicases (RecQL) is involved in the replication/repair of the DNA and in the telomere maintenance. There are 5 enzymes in human and 3 of them are involved in clinically recognizable syndromes: WRN for the Werner syndrome, BLM for the Bloom syndrome and RECQL4 for the Rothmund Thomson syndrome. All are responsive of a high cancer risk due to genomic instability. Molecular and cellular mechanisms involved in these diseases of ageing are unknown. Moreover, for all of them, there is not therapeutic or preventive solution.

Full description

For understanding the involved mechanisms we would like to model the 3 diseases with hiPS (human induced Pluripotent Stem cells) from somatic cells of patients. The patient recruitment was organized by the Montpellier and Nîmes public hospitals.

The project is to generate a hiPS cell line for the 3 syndromes from fibroblasts and/or blood samples. Then, we could induce differentiation of hiPS to a target cell line of the diseases. Finally we could study the disease development following the genomic instability (karyotype, array-CGH) and the cellular ageing (senescence-associated heterochromatin foci, telomere length).

For each mutated enzyme, we will perform a transcriptional profiling (splice, mRNA quantification) and protein studies (western blot). All results will be compared to wild type cells.

Enrollment

3 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patinet with one of the 3 helicase-associated precoce aging desease

Exclusion criteria

  • Minor and /or mentally incapable patient

Trial design

3 participants in 1 patient group

Taking of cutaneous cells by biopsy
Description:
Taking of cutaneous cells by biopsy and a sample of blood
Treatment:
Other: taking of cutaneous cells

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems